Tom McLeer: New VP of Sales and Marketing at LinkSPINE

Tom McLeer has been named the new Vice President (VP) of Sales and Marketing at LinkSPINE, a sister company of Waldemar Link GmbH of Hamburg Germany.

According to the March 7, 2017 news release, “McLeer is an established medical device executive leader who has made a name in the industry by exponentially boosting sales for existing companies and leading startups through clinical approval and into full commercialization. He most recently served as Senior Vice President of US Commercial Operations for Alphatec Spine. Previously, he was CMO and General Manager of Spinal Operations for Pioneer Surgical Technology and VP of Sales and Marketing for Archus Orthopedics. Earlier in his career, McLeer was VP of Marketing and Business Development for Spinal Concepts and VP of Marketing for Interpore Cross International.”

“We are excited to welcome Tom McLeer to the LinkSPINE team to lead our Sales and Marketing efforts,” said LinkSPINE President Dennis Farrell. “Tom’s deep leadership experience in spine and familiarity with novel technologies will be invaluable to us as we continue to expand our less invasive Midline Choice product portfolio.”

“I’m excited to be part of such a great team and I look forward to working with my existing contacts to help advance this minimally invasive procedure to a wide patient population,” said McLeer. “I was drawn to LinkSPINE’s dedicated focus on improving patient outcomes—and it’s innovative portfolio of powerful, yet simple solutions for less invasive surgery. The devices are novel, elegant and intuitive and fulfill a desire for a simple, less invasive approach to lumbar surgery, adding true value for surgeons who are tiring of long learning curves. It will be rewarding to be part of the company’s growth and success.”

McLeer told OTW, “One of the things that most impressed me and drew me to LinkSPINE is the significant development effort the company has made with the ‘MidLine Choice’ suite of products. My first efforts at LinkSPINE will be focused around gathering like-minded surgeons to help us educate the market on our MidLine options. These products offer the strongest biomechanics through the smallest incision on the market—and certainly address a need.”